David Potter

Affiliations: 
Harvard Medical School, Boston, MA, United States 
Google:
"David Potter"
Mean distance: 11.82 (cluster 11)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Conway SM, Puttick D, Russell S, et al. (2019) Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation. Neuropharmacology. 146: 231-241
Van't Veer A, Bechtholt AJ, Onvani S, et al. (2013) Ablation of kappa-opioid receptors from brain dopamine neurons has anxiolytic-like effects and enhances cocaine-induced plasticity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1585-97
Chartoff EH, Papadopoulou M, MacDonald ML, et al. (2009) Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Molecular Pharmacology. 75: 704-12
Chartoff EH, Potter D, Damez-Werno D, et al. (2008) Exposure to the selective kappa-opioid receptor agonist salvinorin A modulates the behavioral and molecular effects of cocaine in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 2676-87
Matsumoto SG, Sah D, Potter DD, et al. (1987) Synaptic functions in rat sympathetic neurons in microcultures. IV. Nonadrenergic excitation of cardiac myocytes and the variety of multiple-transmitter states. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 7: 380-90
See more...